Saunus’s research found that EGFR, ERBB2, and ERBB3 transcripts were abundantly expressed in lung cancer brain metastases, and ERBB3 transcript abundance correlated with its oncogenic partner ERBB2 (34). Here, EGFR is linked to lung carcinoma.